If a patient on hormonal contraceptives (HC) is complaining about lack of interest in sex, one of the first things to think about is stopping her contraceptive.
If a patient on hormonal contraceptives (HC) is complaining about lack of interest in sex, one of the first things to think about is stopping her contraceptive. According to a paper presented at this year's ASRM conference, about 15% of women on oral, transvaginal, or transdermal contraceptives experience diminished libido and vaginal dryness. When researchers from UCLA instructed patients experiencing such sexual problems to stop their HC, they noticed a significant improvement in libido, arousal, lubrication, and orgasm. While the study only involved 11 patients, the investigators nevertheless found that these sexual improvements correlated with changes in serum testosterone and sex hormone-binding globulin, suggesting that the "anti-androgenic" features of HC may have a downside. (Abstract O-195 Fertil Steril. Vol 82; Suppl 2, 2004).
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More